Skip to content

Avantor AVTR EBITDA margin

EBITDA margin at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
24.2%-0.2pp
Danaher logo
DanaherDHR
29.2%-0.9pp
Agilent Technologies logo
Agilent TechnologiesA
25.3%-0.2pp
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
25.8%+1.2pp
Element Solutions logo
Element SolutionsESI
19%-1.1pp
Westlake logo
WestlakeWLK
-4.9%-19.4pp

Other financials

Income statement

See full
Revenue$1.6B0.0%
Gross profit$500.7M-6.4%
Operating income$99.5M-32.5%
Net income$43.3M-32.9%
EPS (diluted)$0.06-33.3%

Balance sheet

See full
Cash & equivalents$282.2M-11.4%
Total debt$3.8B-7.1%
Total equity$5.6B-8.4%
Total assets$11.7B-5.4%

Cash flow

See full
Operating cash flow$58.7M-46.3%
CapEx$33.5M+19.6%
Free cash flow$25.2M-69.0%

Valuation

See full
Market cap$6.54B-52.0%
Enterprise value$10.07B-40.4%
P/S-1.0×

Profitability

See full
Gross margin32.1%-1.4pp
Operating margin4%-5.2pp
Net margin-9.2%-19.9pp
FCF margin6.7%-3.3pp

Returns & leverage

See full
Return on equity-10.3%-22.8pp
Debt / equity0.7×0.0×
Current ratio1.8×+0.6×

Where this comes from

Calculated from Avantor’s reported figures.

Based on trailing twelve months.

The official record: Avantor’s 10-Q, filed October 29, 2025, on SEC EDGAR. View the filing →

Ask your AI about Avantor's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avantor's EBITDA margin?
Avantor (AVTR) reported EBITDA margin of 10.2% in Q3 2025.
How has Avantor's EBITDA margin changed year-over-year?
Avantor's EBITDA margin decreased by 32.5% year-over-year, from 15.2% to 10.2%.
What is the long-term trend for Avantor's EBITDA margin?
Over 4 years (2020 to 2024), Avantor's EBITDA margin has grown at a 6.2% compound annual growth rate (CAGR), from 17.2% to 22%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.